Volume 13, Issue 3, Pages (February 2004)

Slides:



Advertisements
Similar presentations
Volume 56, Issue 5, Pages (November 1999)
Advertisements

Volume 133, Issue 1, Pages (July 2007)
Volume 68, Issue 4, Pages (October 2005)
Volume 14, Issue 6, Pages (June 2001)
A novel SHP-1/Grb2–dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling.
Volume 9, Issue 5, Pages (November 1998)
Volume 11, Issue 6, Pages (June 2003)
Volume 132, Issue 4, Pages (April 2007)
Volume 133, Issue 1, Pages (July 2007)
Volume 8, Issue 1, Pages (July 2001)
Volume 8, Issue 5, Pages (November 2001)
Volume 87, Issue 7, Pages (December 1996)
Volume 89, Issue 5, Pages (May 1997)
Volume 22, Issue 5, Pages (May 2012)
Volume 56, Issue 5, Pages (November 1999)
Volume 23, Issue 1, Pages (July 2006)
ASK1 Is Essential for JNK/SAPK Activation by TRAF2
J. Zhu, N. Sun, L. Aoudjit, H. Li, H. Kawachi, S. Lemay, T. Takano 
Ganglioside GM3 Promotes Carcinoma Cell Proliferation via Urokinase Plasminogen Activator-Induced Extracellular Signal-Regulated Kinase-Independent p70S6.
Volume 19, Issue 6, Pages (September 2005)
Volume 7, Issue 6, Pages (December 2004)
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Volume 15, Issue 6, Pages (December 2001)
Volume 132, Issue 4, Pages (April 2007)
Volume 36, Issue 6, Pages (June 2012)
Volume 18, Issue 23, Pages (December 2008)
Stefanie S. Schalm, Diane C. Fingar, David M. Sabatini, John Blenis 
Volume 29, Issue 3, Pages (February 2008)
Arachidonic acid induces ERK activation via Src SH2 domain association with the epidermal growth factor receptor  L.D. Alexander, Y. Ding, S. Alagarsamy,
MyD88: An Adapter That Recruits IRAK to the IL-1 Receptor Complex
Volume 13, Issue 3, Pages (February 2004)
Volume 9, Issue 6, Pages (June 2011)
PKCδ Clustering at the Leading Edge and Mediating Growth Factor-Enhanced, but not ECM-Initiated, Dermal Fibroblast Migration  Jianhua Fan, Shengxi Guan,
Upregulation of Tenascin-C Expression by IL-13 in Human Dermal Fibroblasts via the Phosphoinositide 3-kinase/Akt and the Protein Kinase C Signaling Pathways 
Monica Kong-Beltran, Jennifer Stamos, Dineli Wickramasinghe 
Contribution of Src-FAK signaling to the induction of connective tissue growth factor in renal fibroblasts  A. Graness, I. Cicha, M. Goppelt-Struebe 
Ligand-Independent Recruitment of SRC-1 to Estrogen Receptor β through Phosphorylation of Activation Function AF-1  André Tremblay, Gilles B Tremblay,
Volume 22, Issue 2, Pages (April 2006)
Volume 10, Issue 1, Pages (July 2002)
Paxillin Serves as an ERK-Regulated Scaffold for Coordinating FAK and Rac Activation in Epithelial Morphogenesis  Shuta Ishibe, Dominique Joly, Zhen-Xiang.
Lysine 63 Polyubiquitination of the Nerve Growth Factor Receptor TrkA Directs Internalization and Signaling  Thangiah Geetha, Jianxiong Jiang, Marie W.
c-Src Activates Endonuclease-Mediated mRNA Decay
The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration  Y. Rebecca Chin, Alex Toker  Molecular.
Gangliosides Inhibit Urokinase-Type Plasminogen Activator (uPA)-Dependent Squamous Carcinoma Cell Migration by Preventing uPA Receptor/α5β1 Integrin/Epidermal.
TIMP-2 Mediated Inhibition of Angiogenesis
Volume 31, Issue 6, Pages (December 2009)
Volume 16, Issue 14, Pages (July 2006)
Volume 10, Issue 22, Pages (November 2000)
Volume 10, Issue 7, Pages (April 2000)
Volume 20, Issue 3, Pages (July 2017)
Tzu-Ching Meng, Toshiyuki Fukada, Nicholas K Tonks  Molecular Cell 
Kimita Suyama, Irina Shapiro, Mitchell Guttman, Rachel B. Hazan 
Amanda O'Donnell, Shen-Hsi Yang, Andrew D. Sharrocks  Molecular Cell 
LAT Links the Pre-BCR to Calcium Signaling
Volume 32, Issue 2, Pages (February 2010)
Volume 129, Issue 2, Pages (April 2007)
Volume 125, Issue 4, Pages (May 2006)
John M Schmitt, Philip J.S Stork  Molecular Cell 
Hua Gao, Yue Sun, Yalan Wu, Bing Luan, Yaya Wang, Bin Qu, Gang Pei 
Volume 33, Issue 5, Pages (November 2010)
Livio Trusolino, Andrea Bertotti, Paolo M Comoglio  Cell 
Volume 12, Issue 3, Pages (March 2000)
Phosphorylation and Functional Inactivation of TSC2 by Erk
Volume 23, Issue 2, Pages (August 2005)
PKCζ is tyrosine phosphorylated by EGF and contributes to EGF-induced activation of ERK in Mef cells. PKCζ is tyrosine phosphorylated by EGF and contributes.
Expression of dominant-negative RasN17 completely suppresses Ras activation in Rh1 cells. Expression of dominant-negative RasN17 completely suppresses.
EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma  David Liu, Julio A.Aguirre Ghiso,
Volume 12, Issue 6, Pages (March 2002)
A Novel Role for FAK as a Protease-Targeting Adaptor Protein
Volume 14, Issue 6, Pages (June 2001)
Presentation transcript:

Volume 13, Issue 3, Pages 341-355 (February 2004) Shp2 Regulates Src Family Kinase Activity and Ras/Erk Activation by Controlling Csk Recruitment  Si Qing Zhang, Wentian Yang, Maria I. Kontaridis, Trever G. Bivona, Gengyun Wen, Toshiyuki Araki, Jincai Luo, Julie A. Thompson, Burkhart L. Schraven, Mark R. Philips, Benjamin G. Neel  Molecular Cell  Volume 13, Issue 3, Pages 341-355 (February 2004) DOI: 10.1016/S1097-2765(04)00050-4 Copyright © 2004 Cell Press Terms and Conditions

Figure 1 Decreased SFK Activation in Shp2−/− Cells (A and B) SFK activation site tyrosines are hypophosphorylated and C-terminal inhibitory tyrosines are hyperphosphorylated in Shp2−/− cells. Serum-starved WT, Shp2−/−, and Rescue cells were treated with PDGF (50 ng/ml), EGF (50 ng/ml), or FGF (40 ng/ml). (A) Lysates resolved by SDS-PAGE were immunoblotted with phospho-specific Src antibodies. (B) Immunoprecipitates with rabbit anti-Src Ab (left) or MAb 327 (right) were immunoblotted with the indicated p-Src Ab. Blots were stripped and reprobed with rabbit anti-Src Ab. (C) Src activity is decreased in Shp2−/− cells. Starved or EGF-stimulated cell lysates were subjected to immune complex kinase assays. (D) Defective β1 Integrin-evoked SFK activation in Shp2−/− cells. Shp2−/− and Rescue cells were plated onto FN-coated plates in serum-free medium, and Src phosphorylation was analyzed by immunoblotting. To control for loading, blots were reprobed with rabbit anti-total Src Ab. Results shown for each panel are representative of two to five experiments. Numbers below each panel represent intensities of pSrc416 or pSrc529 adjusted to total Src levels, and normalized to a value of 1.0 for unstimulated Rescue cells. Molecular Cell 2004 13, 341-355DOI: (10.1016/S1097-2765(04)00050-4) Copyright © 2004 Cell Press Terms and Conditions

Figure 2 Multiple SFK Targets Are Hypophosphorylated in Shp2−/− Cells (A) Shp2−/− and Rescue cells were starved, then stimulated with EGF (50 ng/ml). Vav2, p62Dok, and Plcγ1 immunoprecipitates were subjected to SDS-PAGE and anti-pY or anti-pPlcγ1 immunoblotting, as indicated, then stripped and reprobed with anti-total p62Dok, Vav2, or Plcγ1 Ab, respectively. (B) The indicated cells were plated onto FN-coated plates in serum-free medium. Anti-Fak and anti-p190RhoGAP immunoprecipitates were subjected to anti-pY immunoblotting, then blots were reprobed for Fak and p190RhoGAP. (C) Hypophosphorylated proteins in Shp2−/− cells are SFK targets. The indicated immunoprecipitates from SYF−/−+Src and SYF−/− cells, respectively, were subjected to anti-pY immunoblotting. Blots were stripped and reprobed with anti-total p62Dok, Vav2, Plcγ1, or p190RhoGAP Ab. Molecular Cell 2004 13, 341-355DOI: (10.1016/S1097-2765(04)00050-4) Copyright © 2004 Cell Press Terms and Conditions

Figure 3 Acute Deletion of Shp2 Also Leads to Defective SFK Activation flShp2/flShp2 fibroblasts were infected with AdGFP or AdCre/GFP, followed by sorting for GFP+ cells. After stimulation with EGF (50 ng/ml), FGF (40 ng/ml), or PDGF (50 ng/ml) for 5 min, WT (AdGFP-infected) and KO (AdCre/GFP) lysates were immunoblotted with the indicated Ab. Under these conditions, about 80% of cells were deleted for Shp2. Numbers beneath the panel represent normalized intensities as in Figure 1, corrected for deletion efficiency (by applying a weighted average for the respective contribution of deleted and nondeleted cells). Molecular Cell 2004 13, 341-355DOI: (10.1016/S1097-2765(04)00050-4) Copyright © 2004 Cell Press Terms and Conditions

Figure 4 Shp2 Regulates Tyrosyl Phosphorylation of PAG (A) Left: 293 cells were transfected with Flag-PAG (2 μg), WT Shp2 (0.5–4 μg), and/or the Shp C459S (C/S) mutant (0.5–4 μg). After 24 hr, lysates from randomly growing cells were subjected to anti-Flag immunoprecipitations and anti-pY immunoblotting, and then reprobed with Flag Ab. Right: 293 cells transfected with Flag-PAG (2 μg) and either Shp2 WT or C/S (4 μg), as indicated, were lysed, immunoprecipitated with Flag Ab, and immunoblotted with Shp2 Ab. WT and mutant Shp2 expression in the total cell lysate also is shown. Note that Shp2 associates with PAG and this association is enhanced in cells expressing the substrate-trapping mutant Shp2 C/S. (B) 293 cells were transfected with the indicated combinations of Flag-PAG (2 μg), WT Shp2 (4 μg), and/or Shp2C/S (4 μg). After 24 hr, cells were starved overnight and stimulated with EGF (50 ng/ml) for 10 min or left unstimulated. PAG phosphorylation was analyzed as in (A). (C) 293 cells transfected as in (B) were plated onto FN-coated plates, and PAG phosphorylation was measured as in (A). Numbers beneath each panel represent Flag-PAG tyrosyl phosphorylation normalized to Flag-PAG levels and adjusted so that basal Flag-PAG tyrosyl phosphorylation equals 1.0. Molecular Cell 2004 13, 341-355DOI: (10.1016/S1097-2765(04)00050-4) Copyright © 2004 Cell Press Terms and Conditions

Figure 5 Shp2 Regulates Csk Localization and SFK Activation via PAG (A) Shp2 regulates endogenous PAG tyrosyl phosphorylation. Lysates from Rescue and Shp2−/− cells were subjected to immunoprecipitation with nonimmune (NI) or Csk Ab (left), or PAG Ab (right), followed by anti-pY immunoblotting. Blots were reprobed with Csk MAb or PAG Ab, respectively. The Csk-associated 90 kDa phosphotyrosyl protein (pp90) comigrates with tyrosyl phosphorylated PAG (data not shown). The blots shown represent one of three experiments. (B) Shp2 regulates Csk localization. Shp2−/− and Rescue cells on coverslips were transfected with Csk-GFP (5 μg), starved, and stimulated with EGF (50 ng/ml) for 10 min or left untreated. GFP images were obtained with a confocal microscope. (C) Stable overexpression of dominant-negative PAG in Shp2−/− cells. Shp2−/− cells were infected with pBabePAGY314F, pBabeShp2 (Rescue), or pBabe alone. PAG expression was detected by immunoblotting. (D) Dominant-negative PAG enhances RTK-evoked SFK activation. Shp2−/− cells expressing Shp2 (rescue), empty vector (pBabe), or PAGY314F were stimulated with EGF (50 ng/ml) or PDGF (50 ng/ml), and lysates were immunoblotted with anti-pSrc Ab. (E) Csk binding site in Paxillin is hyperphosphorylated in the absence of functional Shp2. Rescue and Shp2−/− cells were stimulated with EGF (50 ng/ml) for 5 min. Lysates were subjected to immunoblotting with the indicated Ab. Molecular Cell 2004 13, 341-355DOI: (10.1016/S1097-2765(04)00050-4) Copyright © 2004 Cell Press Terms and Conditions

Figure 6 Regulation of EM Ras and Erk Activation by Shp2 (A) WT, Shp2−/−, or SYF−/− fibroblasts were cotransfected with GFP-RBD and H-Ras. After 24, cells were starved, stimulated with EGF (40 ng/ml), and imaged by confocal microscopy. Ras activation (detected by GFP-RBD) occurs on PM (arrows) and EM (arrowheads) in WT cells, but only on the PM in cells lacking Shp2 or SFKs. (B) WT, Shp2−/−, or SYF−/− fibroblasts were transfected with GFP-H-Ras (top row) or GFP-RBD and untagged H-Ras alone (middle row) or with Shp2 or Src, respectively (bottom row). Transfected cells were grown in serum overnight and imaged as in (A). Reconstituting Shp2 expression to Shp2−/− cells or Src expression to SYF−/− cells restores EM Ras activation. (C) Growth factor-induced Erk activity is decreased in SYF−/− cells. SYF−/−+Src and SYF−/− cells were starved and stimulated with EGF (50 ng/ml) or PDGF (50 ng/ml). Lysates were immunoblotted with p-Erk Ab and then reprobed with Erk Ab. Note that Erk1 activation (p44) is defective in cells lacking SFKs. (D) Increasing Src activity in Shp2−/− cells enhances Erk activation. Left: Shp2−/− cells were infected with pBabe WT Src or parental pBabe. Stably infected pools were starved and then stimulated with EGF or left unstimulated. Lysates were analyzed by immunoblotting with the indicated Ab and compared to analogous lysates from Rescue cells. Right: Shp2−/− and Rescue cells were transfected with 20 nM Csk siRNA or mock-transfected, starved, and then stimulated with EGF (50 ng/ml) for 10 min. Lysates were immunoblotted with the indicated Ab. Csk siRNA significantly increases Erk activation even though Csk levels are reduced by only ∼40%. (E) PAGY314F increases growth factor-evoked Erk activation. Lysates from starved or EGF-stimulated Rescue cells, vector, or PAGY314F-infected Shp2−/− cells were immunoblotted with p-Erk Ab. The membrane was then reprobed with anti-p42 Erk Ab. Molecular Cell 2004 13, 341-355DOI: (10.1016/S1097-2765(04)00050-4) Copyright © 2004 Cell Press Terms and Conditions

Figure 7 Model for Regulation of Growth Factor and Integrin Signaling by Shp2 (A) Upon RTK stimulation, Shp2 is recruited to the PM, most likely by scaffolding adapters such as Gab1, and promotes SFK activation by dephosphorylating PAG, thereby regulating Csk recruitment. A similar mechanism, perhaps involving proteins such as Shps1/Sirpα1, may explain Shp2 activation of SFK during integrin signaling. (B) Activated SFKs are required for phosphorylation of several key targets, leading to the activation of distinct downstream signaling pathways. One important downstream pathway leads to EM Ras activation and late stage Erk activation via the Plcγ1/RasGRP pathway. Defective phosphorylation/activation of other SFK targets may help explain altered cell spreading, focal adhesions, and/or stress fibers in Shp2-deficient cells. See text for details. Molecular Cell 2004 13, 341-355DOI: (10.1016/S1097-2765(04)00050-4) Copyright © 2004 Cell Press Terms and Conditions